624 related articles for article (PubMed ID: 26520400)
1. Enhanced in vitro osteogenic differentiation of human fetal MSCs attached to 3D microcarriers versus harvested from 2D monolayers.
Shekaran A; Sim E; Tan KY; Chan JK; Choolani M; Reuveny S; Oh S
BMC Biotechnol; 2015 Oct; 15():102. PubMed ID: 26520400
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable ECM-coated PCL microcarriers support scalable human early MSC expansion and in vivo bone formation.
Shekaran A; Lam A; Sim E; Jialing L; Jian L; Wen JT; Chan JK; Choolani M; Reuveny S; Birch W; Oh S
Cytotherapy; 2016 Oct; 18(10):1332-44. PubMed ID: 27503763
[TBL] [Abstract][Full Text] [Related]
3. Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells.
Goh TK; Zhang ZY; Chen AK; Reuveny S; Choolani M; Chan JK; Oh SK
Biores Open Access; 2013 Apr; 2(2):84-97. PubMed ID: 23593561
[TBL] [Abstract][Full Text] [Related]
4. Sub-confluent culture of human mesenchymal stromal cells on biodegradable polycaprolactone microcarriers enhances bone healing of rat calvarial defect.
Lam AT; Sim EJ; Shekaran A; Li J; Teo KL; Goggi JL; Reuveny S; Birch WR; Oh SK
Cytotherapy; 2019 Jun; 21(6):631-642. PubMed ID: 30975604
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable poly-ε-caprolactone microcarriers for efficient production of human mesenchymal stromal cells and secreted cytokines in batch and fed-batch bioreactors.
Lam AT; Li J; Toh JP; Sim EJ; Chen AK; Chan JK; Choolani M; Reuveny S; Birch WR; Oh SK
Cytotherapy; 2017 Mar; 19(3):419-432. PubMed ID: 28017598
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous osteogenesis of MSCs cultured on 3D microcarriers through alteration of cytoskeletal tension.
Tseng PC; Young TH; Wang TM; Peng HW; Hou SM; Yen ML
Biomaterials; 2012 Jan; 33(2):556-64. PubMed ID: 22024363
[TBL] [Abstract][Full Text] [Related]
7. Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells.
Zhang ZY; Teoh SH; Chong MS; Schantz JT; Fisk NM; Choolani MA; Chan J
Stem Cells; 2009 Jan; 27(1):126-37. PubMed ID: 18832592
[TBL] [Abstract][Full Text] [Related]
8. A scalable approach to obtain mesenchymal stem cells with osteogenic potency on apatite microcarriers.
Feng J; Chong M; Chan J; Zhang Z; Teoh SH; Thian ES
J Biomater Appl; 2014 Jul; 29(1):93-103. PubMed ID: 24327350
[TBL] [Abstract][Full Text] [Related]
9. Implications of adipose-derived stromal cells in a 3D culture system for osteogenic differentiation: an in vitro and in vivo investigation.
Shen FH; Werner BC; Liang H; Shang H; Yang N; Li X; Shimer AL; Balian G; Katz AJ
Spine J; 2013 Jan; 13(1):32-43. PubMed ID: 23384881
[TBL] [Abstract][Full Text] [Related]
10. RIA fractions contain mesenchymal stroma cells with high osteogenic potency.
Kuehlfluck P; Moghaddam A; Helbig L; Child C; Wildemann B; Schmidmaier G;
Injury; 2015 Dec; 46 Suppl 8():S23-32. PubMed ID: 26747914
[TBL] [Abstract][Full Text] [Related]
11. Expansion in microcarrier-spinner cultures improves the chondrogenic potential of human early mesenchymal stromal cells.
Lin YM; Lim JF; Lee J; Choolani M; Chan JK; Reuveny S; Oh SK
Cytotherapy; 2016 Jun; 18(6):740-53. PubMed ID: 27173750
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal Stem Cell Spheroids Retain Osteogenic Phenotype Through α2β1 Signaling.
Murphy KC; Hoch AI; Harvestine JN; Zhou D; Leach JK
Stem Cells Transl Med; 2016 Sep; 5(9):1229-37. PubMed ID: 27365484
[TBL] [Abstract][Full Text] [Related]
13. Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactors.
Rafiq QA; Coopman K; Nienow AW; Hewitt CJ
Biotechnol J; 2016 Mar; 11(4):473-86. PubMed ID: 26632496
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic differentiation of human mesenchymal stem cells in mineralized alginate matrices.
Westhrin M; Xie M; Olderøy MØ; Sikorski P; Strand BL; Standal T
PLoS One; 2015; 10(3):e0120374. PubMed ID: 25769043
[TBL] [Abstract][Full Text] [Related]
15. Adhesion, proliferation and osteogenic differentiation of mesenchymal stem cells in 3D printed poly-ε-caprolactone/hydroxyapatite scaffolds combined with bone marrow clots.
Zheng P; Yao Q; Mao F; Liu N; Xu Y; Wei B; Wang L
Mol Med Rep; 2017 Oct; 16(4):5078-5084. PubMed ID: 28849142
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential.
Jung J; Moon N; Ahn JY; Oh EJ; Kim M; Cho CS; Shin JC; Oh IH
Stem Cells Dev; 2009 May; 18(4):559-71. PubMed ID: 18754716
[TBL] [Abstract][Full Text] [Related]
17. Multiomics analyses of cytokines, genes, miRNA, and regulatory networks in human mesenchymal stem cells expanded in stirred microcarrier-spinner cultures.
Lam AT; Lee AP; Jayaraman P; Tan KY; Raghothaman D; Lim HL; Cheng H; Zhou L; Tan AH; Reuveny S; Oh S
Stem Cell Res; 2021 May; 53():102272. PubMed ID: 33676128
[TBL] [Abstract][Full Text] [Related]
18. A single short session of media perfusion induces osteogenesis in hBMSCs cultured in porous scaffolds, dependent on cell differentiation stage.
Filipowska J; Reilly GC; Osyczka AM
Biotechnol Bioeng; 2016 Aug; 113(8):1814-24. PubMed ID: 26806539
[TBL] [Abstract][Full Text] [Related]
19. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential.
Frith JE; Thomson B; Genever PG
Tissue Eng Part C Methods; 2010 Aug; 16(4):735-49. PubMed ID: 19811095
[TBL] [Abstract][Full Text] [Related]
20. 3D Scaffolds with Different Stiffness but the Same Microstructure for Bone Tissue Engineering.
Chen G; Dong C; Yang L; Lv Y
ACS Appl Mater Interfaces; 2015 Jul; 7(29):15790-802. PubMed ID: 26151287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
